Eighteen percent of all improperly used thrombolytic treatments in the emergency department occur in patients with migraine with aura.
Efficacy and Safety of Fremanezumab Consistent in Patients With Migraine and Obesity
Episode 92: Highlights From the 2023 CMSC, SLEEP, AHS, and ATMRD Annual Meetings
Long-Term Atogepant Effective, Safe as Migraine Preventive, Open-Label Studies Show
Episode 88: 2023 AAN Annual Meeting Highlights
NeurologyLive® Brain Games: April 14, 2024
Pooled Phase 3 Studies Highlight AXS-07 as Effective Migraine Treatment